CENOVUS ENERGY INC - CVECN 3.94 PERP (CVE-PR-B.CA) Fundamental Analysis & Valuation

TSX:CVE-PR-B • CA15135U4063

25.22 CAD
+0.02 (+0.08%)
Last: Mar 11, 2026, 07:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This CVE-PR-B.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

6

Overall CVE-PR-B gets a fundamental rating of 6 out of 10. We evaluated CVE-PR-B against 212 industry peers in the Oil, Gas & Consumable Fuels industry. CVE-PR-B has an average financial health and profitability rating. CVE-PR-B is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

6

1. CVE-PR-B.CA Profitability Analysis

1.1 Basic Checks

  • In the past year CVE-PR-B was profitable.
  • In the past year CVE-PR-B had a positive cash flow from operations.
  • Each year in the past 5 years CVE-PR-B has been profitable.
  • In the past 5 years CVE-PR-B always reported a positive cash flow from operatings.
CVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCVE-PR-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B

1.2 Ratios

  • The Return On Assets of CVE-PR-B (6.17%) is better than 87.26% of its industry peers.
  • CVE-PR-B's Return On Equity of 12.38% is amongst the best of the industry. CVE-PR-B outperforms 83.96% of its industry peers.
  • The Return On Invested Capital of CVE-PR-B (6.85%) is better than 87.26% of its industry peers.
  • CVE-PR-B had an Average Return On Invested Capital over the past 3 years of 8.35%. This is in line with the industry average of 6.67%.
Industry RankSector Rank
ROA 6.17%
ROE 12.38%
ROIC 6.85%
ROA(3y)6.41%
ROA(5y)6.35%
ROE(3y)12.34%
ROE(5y)12.52%
ROIC(3y)8.35%
ROIC(5y)10.5%
CVE-PR-B.CA Yearly ROA, ROE, ROICCVE-PR-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 7.88%, CVE-PR-B is in the better half of the industry, outperforming 62.26% of the companies in the same industry.
  • In the last couple of years the Profit Margin of CVE-PR-B has declined.
  • CVE-PR-B has a Operating Margin (9.54%) which is in line with its industry peers.
  • CVE-PR-B's Operating Margin has declined in the last couple of years.
  • CVE-PR-B's Gross Margin of 34.22% is in line compared to the rest of the industry. CVE-PR-B outperforms 54.72% of its industry peers.
  • In the last couple of years the Gross Margin of CVE-PR-B has declined.
Industry RankSector Rank
OM 9.54%
PM (TTM) 7.88%
GM 34.22%
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-6.34%
PM growth 5YN/A
GM growth 3Y-11.56%
GM growth 5Y-11%
CVE-PR-B.CA Yearly Profit, Operating, Gross MarginsCVE-PR-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CVE-PR-B.CA Health Analysis

2.1 Basic Checks

  • CVE-PR-B has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, CVE-PR-B has more shares outstanding
  • CVE-PR-B has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, CVE-PR-B has a worse debt to assets ratio.
CVE-PR-B.CA Yearly Shares OutstandingCVE-PR-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
CVE-PR-B.CA Yearly Total Debt VS Total AssetsCVE-PR-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • CVE-PR-B has an Altman-Z score of 2.26. This is not the best score and indicates that CVE-PR-B is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CVE-PR-B's Altman-Z score of 2.26 is fine compared to the rest of the industry. CVE-PR-B outperforms 72.17% of its industry peers.
  • CVE-PR-B has a debt to FCF ratio of 4.28. This is a neutral value as CVE-PR-B would need 4.28 years to pay back of all of its debts.
  • CVE-PR-B's Debt to FCF ratio of 4.28 is amongst the best of the industry. CVE-PR-B outperforms 83.49% of its industry peers.
  • A Debt/Equity ratio of 0.44 indicates that CVE-PR-B is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.44, CVE-PR-B is in line with its industry, outperforming 52.83% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.28
Altman-Z 2.26
ROIC/WACC0.95
WACC7.23%
CVE-PR-B.CA Yearly LT Debt VS Equity VS FCFCVE-PR-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B

2.3 Liquidity

  • CVE-PR-B has a Current Ratio of 1.57. This is a normal value and indicates that CVE-PR-B is financially healthy and should not expect problems in meeting its short term obligations.
  • CVE-PR-B's Current ratio of 1.57 is fine compared to the rest of the industry. CVE-PR-B outperforms 73.11% of its industry peers.
  • CVE-PR-B has a Quick Ratio of 1.04. This is a normal value and indicates that CVE-PR-B is financially healthy and should not expect problems in meeting its short term obligations.
  • CVE-PR-B has a better Quick ratio (1.04) than 67.45% of its industry peers.
Industry RankSector Rank
Current Ratio 1.57
Quick Ratio 1.04
CVE-PR-B.CA Yearly Current Assets VS Current LiabilitesCVE-PR-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CVE-PR-B.CA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.49% over the past year.
  • The earnings per share for CVE-PR-B have been decreasing by -10.45% on average. This is quite bad
  • Looking at the last year, CVE-PR-B shows a decrease in Revenue. The Revenue has decreased by -8.44% in the last year.
  • Measured over the past years, CVE-PR-B shows a very strong growth in Revenue. The Revenue has been growing by 30.31% on average per year.
EPS 1Y (TTM)30.49%
EPS 3Y-10.45%
EPS 5YN/A
EPS Q2Q%614.29%
Revenue 1Y (TTM)-8.44%
Revenue growth 3Y-9.43%
Revenue growth 5Y30.31%
Sales Q2Q%-15.06%

3.2 Future

  • CVE-PR-B is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.99% yearly.
  • CVE-PR-B is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.92% yearly.
EPS Next Y-54.6%
EPS Next 2Y-6.64%
EPS Next 3Y7.94%
EPS Next 5Y20.99%
Revenue Next Year-16.99%
Revenue Next 2Y-6.2%
Revenue Next 3Y-5.92%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CVE-PR-B.CA Yearly Revenue VS EstimatesCVE-PR-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 20B 40B 60B
CVE-PR-B.CA Yearly EPS VS EstimatesCVE-PR-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 -2 4

More info and screens

Find the best growth stocksShow best growing peers

6

4. CVE-PR-B.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 11.79 indicates a reasonable valuation of CVE-PR-B.
  • Based on the Price/Earnings ratio, CVE-PR-B is valued a bit cheaper than the industry average as 74.06% of the companies are valued more expensively.
  • CVE-PR-B is valuated cheaply when we compare the Price/Earnings ratio to 26.15, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 25.96 indicates a quite expensive valuation of CVE-PR-B.
  • Based on the Price/Forward Earnings ratio, CVE-PR-B is valued a bit cheaper than the industry average as 62.26% of the companies are valued more expensively.
  • CVE-PR-B's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.27.
Industry RankSector Rank
PE 11.79
Fwd PE 25.96
CVE-PR-B.CA Price Earnings VS Forward Price EarningsCVE-PR-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CVE-PR-B is valued cheaper than 87.74% of the companies in the same industry.
  • 80.66% of the companies in the same industry are more expensive than CVE-PR-B, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.28
EV/EBITDA 5.93
CVE-PR-B.CA Per share dataCVE-PR-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The decent profitability rating of CVE-PR-B may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-6.64%
EPS Next 3Y7.94%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. CVE-PR-B.CA Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.56%, CVE-PR-B has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 4.17, CVE-PR-B pays a bit more dividend than its industry peers.
  • CVE-PR-B's Dividend Yield is a higher than the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.56%

5.2 History

  • On average, the dividend of CVE-PR-B grows each year by 65.35%, which is quite nice.
  • CVE-PR-B has been paying a dividend for at least 10 years, so it has a reliable track record.
  • CVE-PR-B has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)65.35%
Div Incr Years3
Div Non Decr Years3
CVE-PR-B.CA Yearly Dividends per shareCVE-PR-B.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 36.70% of the earnings are spent on dividend by CVE-PR-B. This is a low number and sustainable payout ratio.
  • CVE-PR-B's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP36.7%
EPS Next 2Y-6.64%
EPS Next 3Y7.94%
CVE-PR-B.CA Yearly Income VS Free CF VS DividendCVE-PR-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B 6B
CVE-PR-B.CA Dividend Payout.CVE-PR-B.CA Dividend Payout, showing the Payout Ratio.CVE-PR-B.CA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

CVE-PR-B.CA Fundamentals: All Metrics, Ratios and Statistics

CENOVUS ENERGY INC - CVECN 3.94 PERP

TSX:CVE-PR-B (3/11/2026, 7:00:00 PM)

25.22

+0.02 (+0.08%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-19
Earnings (Next)05-06
Inst Owners55.94%
Inst Owner ChangeN/A
Ins Owners0.62%
Ins Owner ChangeN/A
Market Cap47.42B
Revenue(TTM)49.70B
Net Income(TTM)3.92B
Analysts78.18
Price Target31.55 (25.1%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.56%
Yearly Dividend0.78
Dividend Growth(5Y)65.35%
DP36.7%
Div Incr Years3
Div Non Decr Years3
Ex-Date03-13
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.1%
Min EPS beat(2)28.15%
Max EPS beat(2)40.05%
EPS beat(4)4
Avg EPS beat(4)67.87%
Min EPS beat(4)25.67%
Max EPS beat(4)177.6%
EPS beat(8)5
Avg EPS beat(8)23.22%
EPS beat(12)8
Avg EPS beat(12)16.31%
EPS beat(16)10
Avg EPS beat(16)8.98%
Revenue beat(2)0
Avg Revenue beat(2)-13.68%
Min Revenue beat(2)-22.39%
Max Revenue beat(2)-4.97%
Revenue beat(4)0
Avg Revenue beat(4)-9.24%
Min Revenue beat(4)-22.39%
Max Revenue beat(4)-4.15%
Revenue beat(8)2
Avg Revenue beat(8)-4.53%
Revenue beat(12)4
Avg Revenue beat(12)-3.39%
Revenue beat(16)8
Avg Revenue beat(16)2.77%
PT rev (1m)0%
PT rev (3m)14.17%
EPS NQ rev (1m)-23.51%
EPS NQ rev (3m)-25.09%
EPS NY rev (1m)-43.74%
EPS NY rev (3m)-42.27%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)-8.03%
Revenue NY rev (3m)-8.37%
Valuation
Industry RankSector Rank
PE 11.79
Fwd PE 25.96
P/S 0.95
P/FCF 14.28
P/OCF 5.76
P/B 1.5
P/tB 1.65
EV/EBITDA 5.93
EPS(TTM)2.14
EY8.49%
EPS(NY)0.97
Fwd EY3.85%
FCF(TTM)1.77
FCFY7%
OCF(TTM)4.38
OCFY17.35%
SpS26.43
BVpS16.82
TBVpS15.27
PEG (NY)N/A
PEG (5Y)N/A
Graham Number28.46
Profitability
Industry RankSector Rank
ROA 6.17%
ROE 12.38%
ROCE 8.3%
ROIC 6.85%
ROICexc 7.19%
ROICexgc 7.6%
OM 9.54%
PM (TTM) 7.88%
GM 34.22%
FCFM 6.68%
ROA(3y)6.41%
ROA(5y)6.35%
ROE(3y)12.34%
ROE(5y)12.52%
ROIC(3y)8.35%
ROIC(5y)10.5%
ROICexc(3y)8.81%
ROICexc(5y)11.28%
ROICexgc(3y)9.38%
ROICexgc(5y)12.09%
ROCE(3y)10.15%
ROCE(5y)12.76%
ROICexgc growth 3Y-30.32%
ROICexgc growth 5YN/A
ROICexc growth 3Y-29.98%
ROICexc growth 5YN/A
OM growth 3Y-16.68%
OM growth 5YN/A
PM growth 3Y-6.34%
PM growth 5YN/A
GM growth 3Y-11.56%
GM growth 5Y-11%
F-Score7
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 4.28
Debt/EBITDA 1.39
Cap/Depr 94.51%
Cap/Sales 9.87%
Interest Coverage 250
Cash Conversion 82.83%
Profit Quality 84.81%
Current Ratio 1.57
Quick Ratio 1.04
Altman-Z 2.26
F-Score7
WACC7.23%
ROIC/WACC0.95
Cap/Depr(3y)96.67%
Cap/Depr(5y)82.56%
Cap/Sales(3y)9.12%
Cap/Sales(5y)7.68%
Profit Quality(3y)98.85%
Profit Quality(5y)204.67%
High Growth Momentum
Growth
EPS 1Y (TTM)30.49%
EPS 3Y-10.45%
EPS 5YN/A
EPS Q2Q%614.29%
EPS Next Y-54.6%
EPS Next 2Y-6.64%
EPS Next 3Y7.94%
EPS Next 5Y20.99%
Revenue 1Y (TTM)-8.44%
Revenue growth 3Y-9.43%
Revenue growth 5Y30.31%
Sales Q2Q%-15.06%
Revenue Next Year-16.99%
Revenue Next 2Y-6.2%
Revenue Next 3Y-5.92%
Revenue Next 5YN/A
EBIT growth 1Y-6.76%
EBIT growth 3Y-24.54%
EBIT growth 5YN/A
EBIT Next Year104.22%
EBIT Next 3Y32.47%
EBIT Next 5Y22.21%
FCF growth 1Y-21.3%
FCF growth 3Y-24.43%
FCF growth 5YN/A
OCF growth 1Y-10.9%
OCF growth 3Y-10.31%
OCF growth 5Y97.62%

CENOVUS ENERGY INC - CVECN 3.94 PERP / CVE-PR-B.CA FAQ

Can you provide the ChartMill fundamental rating for CENOVUS ENERGY INC - CVECN 3.94 PERP?

ChartMill assigns a fundamental rating of 6 / 10 to CVE-PR-B.CA.


Can you provide the valuation status for CENOVUS ENERGY INC - CVECN 3.94 PERP?

ChartMill assigns a valuation rating of 6 / 10 to CENOVUS ENERGY INC - CVECN 3.94 PERP (CVE-PR-B.CA). This can be considered as Fairly Valued.


How profitable is CENOVUS ENERGY INC - CVECN 3.94 PERP (CVE-PR-B.CA) stock?

CENOVUS ENERGY INC - CVECN 3.94 PERP (CVE-PR-B.CA) has a profitability rating of 6 / 10.


Can you provide the financial health for CVE-PR-B stock?

The financial health rating of CENOVUS ENERGY INC - CVECN 3.94 PERP (CVE-PR-B.CA) is 5 / 10.


What is the expected EPS growth for CENOVUS ENERGY INC - CVECN 3.94 PERP (CVE-PR-B.CA) stock?

The Earnings per Share (EPS) of CENOVUS ENERGY INC - CVECN 3.94 PERP (CVE-PR-B.CA) is expected to decline by -54.6% in the next year.